Senior Vice President of Medical Affairs & Founder, Director of the Board, Chairman of the Board Emeritus, Professor of Pathology, University of Arizona

Dr. Thomas Grogan, founder, is currently the Senior Vice President of Medical Affairs at Ventana Medical Systems. He has served as a director of the company since its formation in June 1985. At Ventana, Dr. Grogan monitors and evaluates the development of novel therapeutics from biotechnology and pharmaceutical companies and assists in the establishment of strategic alliances and other collaborations to develop diagnostic tests for targeted therapeutics. He works closely with Ventana’s engineering team to ensure successful transfer of reagent research products from research to development, and is integrally involved in the successful commercialization of these products on Ventana platforms.

Since 1979, Dr. Grogan has been on the faculty of the University of Arizona and is currently a professor of pathology in the College of Medicine, where he specializes in hematopathology. He is a member of the Lymphoma Biology Committee and founding member of the International Lymphoma Study Group, which formulated the current classification scheme for clinical practice. Dr. Grogan has authored over 200 papers on lymphoma and myeloma, and holds patents for the kinetic-mode process for automated Immunohistochemistry (IHC) and in-situ hybridization (ISH). At the University of Arizona College of Medicine, Dr. Grogan is actively involved in teaching residents, medical students and fellows. His clinical practice contributions have been recognized and named in The Best Doctors In America (Woodward/White) continuously since 1991.

He received his B.A. with distinction (Phi Beta Kappa) from the University of Virginia, in 1967 and his M.D. (AOA, 1971) from the George Washington University School of Medicine. He completed a post-doctorate fellowship in hematopathology at Stanford University.